| 20.94 Delayed Data As of Sep 20 |  +0.22 / +1.06%Today’s Change | 7.26 Today|||52-Week Range 26.59 | +136.61% Year-to-Date |
| Previous close | 20.72 |
| Today’s open | 20.90 |
| Day’s range | 20.66 - 21.67 |
| Volume | 4,799,867 |
| Average volume (3 months) | 1,858,424 |
| Market cap | $2.7B |
| Earnings growth (last year) | +9.90% |
| Earnings growth (this year) | -17.67% |
| Earnings growth (next 5 years) | -19.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 5.68 |
| Today’s change | Today’s % change | |
|---|---|---|
| EBSEmergent BioSolution... | -0.99 | -1.90% |
| CRSPCRISPR Therapeutics ... | +0.82 | +1.73% |
| ARWRArrowhead Pharmaceut... | -0.23 | -0.79% |
| HALOHalozyme Therapeutic... | +0.08 | +0.49% |
| Next reporting date | November 1, 2019 |
| EPS forecast (this quarter) | -$0.40 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$123.6M |
| Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Maria Fardis |
Secretary, Chief Financial & Accounting Officer Timothy E. Morris |
Corporate headquarters San Carlos, California |
